Research Coverage of Japanese Listed Companies, Shared Research Inc

Shared Research

Our report is an authoritative Owner’s Manual on the company.
- A vital piece in the investor’s toolbox, our report allows you to uncover the essence of the business
- We pinpoint strengths and weaknesses; discuss strategy
- Our aim is to make deep knowledge about the company readily available, saving investors time and enabling dialogue

We offer our research as a service for Japanese corporates.
- Our in-depth reports allow them to better inform investors by presenting an unbiased third-party view of business fundamentals
- Our reports do not offer investment opinions and are free for all investors

We start our coverage with a substantial core report.
- We continuously update this report to reflect earnings, news flow, and any material developments
- We thoroughly interview management on a quarterly basis

Research Coverage of Japanese Listed Companies

Shared Research Inc

Pioneering research coverage of Japanese listed companies. Now customizable and interactive for global institutional investors. Corporate access reimagined.

Equity Bottom-Up

<ul><li>Operating revenue increased 45.2% YoY to JPY7.3bn, driven by US sales growth of absorbable local hemostat TDM-621.</li><li>Operating profit reached JPY707mn, a significant improvement from a JPY606mn loss in cumulative Q3 FY04/25.</li><li>Revised FY04/26 forecast projects operating revenue of JPY9.9bn and operating profit of JPY961mn, reflecting strong US market performance.</li></ul>

Operating revenue increased 45.2% YoY to JPY7.3bn, driven by US sales growth of absorbable local hemostat TDM-621.Operating profit reached JPY707mn, a significant improvement from a JPY606mn loss in cumulative Q3 FY04/25.Revised FY04/26 forecast projects operating revenue of JPY9.9bn and operating profit of JPY961mn, reflecting strong US market performance.

3Dマトリックス株式会社（7777 JP）：2004/26年度第3四半期速報

3 D Matrix Ltd

3Dマトリックス株式会社（7777 JP）：2004/26年度第3四半期速報